Literature DB >> 25273292

CBT for severe mental disorder: a good product that is in danger of being over-extended.

Peter Tyrer1.   

Abstract

Entities:  

Year:  2014        PMID： 25273292      PMCID： PMC4219060          DOI： 10.1002/wps.20159

Source DB:  PubMed          Journal:  World Psychiatry        ISSN： 1723-8617            Impact factor:   49.548


× No keyword cloud information.
  11 in total

1.  Cognitive-behavioural therapy v. social activity therapy for people with psychosis and a history of violence: randomised controlled trial.

Authors:  Gillian Haddock; Christine Barrowclough; Jennifer J Shaw; Graham Dunn; Raymond W Novaco; Nicholas Tarrier
Journal:  Br J Psychiatry       Date:  2009-02       Impact factor: 9.319

Review 2.  Efficacy of cognitive-behavioural therapy and other psychological treatments for adult depression: meta-analytic study of publication bias.

Authors:  Pim Cuijpers; Filip Smit; Ernst Bohlmeijer; Steven D Hollon; Gerhard Andersson
Journal:  Br J Psychiatry       Date:  2010-03       Impact factor: 9.319

3.  Nidotherapy for schizophrenia.

Authors:  Ian J Chamberlain; Stephanie Sampson
Journal:  Schizophr Bull       Date:  2012-11-30       Impact factor: 9.306

4.  The promise of cognitive behavior therapy for treatment of severe mental disorders: a review of recent developments.

Authors:  Michael E Thase; David Kingdon; Douglas Turkington
Journal:  World Psychiatry       Date:  2014-10       Impact factor: 49.548

5.  DL-propranolol and chlorpromazine following admission for schizophrenia. A controlled comparison.

Authors:  N J Yorkston; S A Zaki; M P Weller; J H Gruzelier; S R Hirsch
Journal:  Acta Psychiatr Scand       Date:  1981-01       Impact factor: 6.392

Review 6.  Anxiety comorbidity in schizophrenia.

Authors:  Raphael J Braga; Graham P Reynolds; Samuel G Siris
Journal:  Psychiatry Res       Date:  2013-08-07       Impact factor: 3.222

7.  Propranolol as an adjunct to the treatment of schizophrenia.

Authors:  N J Yorkston; S A Zaki; D R Pitcher; J H Gruzelier; D Hollander; H G Sergeant
Journal:  Lancet       Date:  1977-09-17       Impact factor: 79.321

8.  Cost-effectiveness of nidotherapy for comorbid personality disorder and severe mental illness: randomized controlled trial.

Authors:  Maja Ranger; Peter Tyrer; Katerina Miloseska; Hannalie Fourie; Ibrahim Khaleel; Bernard North; Barbara Barrett
Journal:  Epidemiol Psichiatr Soc       Date:  2009 Apr-Jun

Review 9.  Conceptual framework for personal recovery in mental health: systematic review and narrative synthesis.

Authors:  Mary Leamy; Victoria Bird; Clair Le Boutillier; Julie Williams; Mike Slade
Journal:  Br J Psychiatry       Date:  2011-12       Impact factor: 9.319

10.  Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial.

Authors:  Christine Barrowclough; Gillian Haddock; Til Wykes; Ruth Beardmore; Patricia Conrod; Tom Craig; Linda Davies; Graham Dunn; Emily Eisner; Shôn Lewis; Jan Moring; Craig Steel; Nicholas Tarrier
Journal:  BMJ       Date:  2010-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.